Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1999-12

AUTHORS

P. Ebeling, A. -M. Teppo, H. A. Koistinen, J. Viikari, T. Rönnemaa, M. Nissén, S. Bergkulla, P. Salmela, J. Saltevo, V. A. Koivisto

ABSTRACT

AIMS/HYPOTHESIS: Inflammation could play a part in insulin resistance. Thiazolidinediones, new antidiabetic drugs, possess anti-inflammatory effects in vitro. We investigated if acute-phase serum proteins are increased in patients with Type II (non-insulin-dependent) diabetes mellitus who had been treated with insulin and whether troglitazone has anti-inflammatory effects in vivo. METHODS: A total of 27 patients (age 63.0+/-1.7 years, HbA1c 8.8+/-0.3%, BMI 32.7+/-0.8 kg/m2, duration 15.2+/-1.4 years, insulin dose 73.3+/-7.0 U/day) participated in the study. The patients received daily either 400 mg troglitazone or placebo for 16 weeks. Blood samples were taken at baseline, at the end of therapy and after a follow-up time of 23+/-4 days. RESULTS: The concentrations of serum amyloid A (6.2+/-1.1 mg/l) and C-reactive protein (6.1+/-1.1 mg/l) were increased (p < 0.001) and complement protein C3 (1.69+/-0.05 g/l) was also above the reference range for healthy subjects. Placebo treatment had no effect on glucose or inflammation, whereas troglitazone reduced fasting glucose (from 10.4+/-0.6 mmol/l to 8.1+/-0.5 mmol/l, p < 0.01), HbA1c (from 8.7+/-0.3% to 7.5+/-0.3%, p < 0.01), insulin requirements (from 75+/-10 U/day to 63+/-10 U/day, p < 0.05), serum amyloid A (from 6.3+/-1.5 mg/l to 4.0+/-1.3 mg/l, p = 0.001), alpha-1-acid glycoprotein (from 906+/-51 mg/l to 729+/-52 mg/l, p = 0.001) and C3 (from 1.72+/-0.07 g/l to 1.66+/-0.06 g/l, p < 0.05) but not alpha-1-antitrypsin, ceruloplasmin, C-reactive protein or haptoglobin significantly. Concentrations of glucose and acute-phase reactants had returned to those before treatment at the follow-up visit. CONCLUSION/INTERPRETATION: In Type II diabetic patients serum amyloid A and complement protein C3 are raised. Troglitazone exerts a selective reversible action on some acute-phase proteins and C3 but not on others in conjunction with the improvement in glucose metabolism. More... »

PAGES

1433-1438

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s001250051315

DOI

http://dx.doi.org/10.1007/s001250051315

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052471842

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/10651262


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute-Phase Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Mass Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Reactive Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Complement C3", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycated Hemoglobin A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Orosomucoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Placebos", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Serum Amyloid A Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazolidinediones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Troglitazone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Helsinki University Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.15485.3d", 
          "name": [
            "Division of Internal Medicine and Geriatrics, Department of Medicine, Helsinki University Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ebeling", 
        "givenName": "P.", 
        "id": "sg:person.0744473260.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744473260.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Helsinki University Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.15485.3d", 
          "name": [
            "Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Teppo", 
        "givenName": "A. -M.", 
        "id": "sg:person.01102740042.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102740042.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Helsinki University Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.15485.3d", 
          "name": [
            "Division of Internal Medicine and Geriatrics, Department of Medicine, Helsinki University Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koistinen", 
        "givenName": "H. A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Department of Medicine, Turku University Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viikari", 
        "givenName": "J.", 
        "id": "sg:person.016547631637.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016547631637.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Department of Medicine, Turku University Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "R\u00f6nnemaa", 
        "givenName": "T.", 
        "id": "sg:person.01076177743.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076177743.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Vaasa Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417201.1", 
          "name": [
            "Department of Medicine, Vaasa Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niss\u00e9n", 
        "givenName": "M.", 
        "id": "sg:person.01071674535.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071674535.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Vaasa Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417201.1", 
          "name": [
            "Department of Medicine, Vaasa Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bergkulla", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oulu University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412326.0", 
          "name": [
            "Department of Medicine, Oulu University Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salmela", 
        "givenName": "P.", 
        "id": "sg:person.0715423117.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715423117.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Central Finland Health Care District", 
          "id": "https://www.grid.ac/institutes/grid.460356.2", 
          "name": [
            "Department of Medicine, Jyv\u00e4skyl\u00e4 Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saltevo", 
        "givenName": "J.", 
        "id": "sg:person.01063043575.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063043575.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Helsinki University Central Hospital", 
          "id": "https://www.grid.ac/institutes/grid.15485.3d", 
          "name": [
            "Division of Internal Medicine and Geriatrics, Department of Medicine, Helsinki University Central Hospital, Finland, FI"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koivisto", 
        "givenName": "V. A.", 
        "id": "sg:person.0606507046.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606507046.23"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm199408183310709", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000631503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0092-8674(00)81359-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001926405"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(95)90194-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002104062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.1982.tb22139.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006279574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2249.1997.3921287.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007691635"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.270.22.12953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015129002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/34184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017942021", 
          "https://doi.org/10.1038/34184"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/34184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017942021", 
          "https://doi.org/10.1038/34184"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0026-0495(89)90038-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026152682"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-5699(94)90138-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028438524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0167-5699(94)90138-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028438524"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199411033311803", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031657081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(95)90193-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035230198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/34178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037539688", 
          "https://doi.org/10.1038/34178"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/34178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037539688", 
          "https://doi.org/10.1038/34178"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037565164", 
          "https://doi.org/10.1007/s001250050901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037565164", 
          "https://doi.org/10.1007/s001250050901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0092-8674(00)81567-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040162482"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046557332", 
          "https://doi.org/10.1007/s001250050822"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001250050822", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046557332", 
          "https://doi.org/10.1007/s001250050822"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-3083.1997.d01-147.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046834839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-3083.1997.d01-147.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046834839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199705223362103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048761446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000186276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053678512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/bi00198a014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055164844"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm950395a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055957129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm950395a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055957129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs0680233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056722386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1042/cs0680233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1056722386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0029-1210817", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057183318"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.44.4.471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070737544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.46.3.451", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070738139"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diacare.15.2.193", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070745623"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1999-12", 
    "datePublishedReg": "1999-12-01", 
    "description": "AIMS/HYPOTHESIS: Inflammation could play a part in insulin resistance. Thiazolidinediones, new antidiabetic drugs, possess anti-inflammatory effects in vitro. We investigated if acute-phase serum proteins are increased in patients with Type II (non-insulin-dependent) diabetes mellitus who had been treated with insulin and whether troglitazone has anti-inflammatory effects in vivo.\nMETHODS: A total of 27 patients (age 63.0+/-1.7 years, HbA1c 8.8+/-0.3%, BMI 32.7+/-0.8 kg/m2, duration 15.2+/-1.4 years, insulin dose 73.3+/-7.0 U/day) participated in the study. The patients received daily either 400 mg troglitazone or placebo for 16 weeks. Blood samples were taken at baseline, at the end of therapy and after a follow-up time of 23+/-4 days.\nRESULTS: The concentrations of serum amyloid A (6.2+/-1.1 mg/l) and C-reactive protein (6.1+/-1.1 mg/l) were increased (p < 0.001) and complement protein C3 (1.69+/-0.05 g/l) was also above the reference range for healthy subjects. Placebo treatment had no effect on glucose or inflammation, whereas troglitazone reduced fasting glucose (from 10.4+/-0.6 mmol/l to 8.1+/-0.5 mmol/l, p < 0.01), HbA1c (from 8.7+/-0.3% to 7.5+/-0.3%, p < 0.01), insulin requirements (from 75+/-10 U/day to 63+/-10 U/day, p < 0.05), serum amyloid A (from 6.3+/-1.5 mg/l to 4.0+/-1.3 mg/l, p = 0.001), alpha-1-acid glycoprotein (from 906+/-51 mg/l to 729+/-52 mg/l, p = 0.001) and C3 (from 1.72+/-0.07 g/l to 1.66+/-0.06 g/l, p < 0.05) but not alpha-1-antitrypsin, ceruloplasmin, C-reactive protein or haptoglobin significantly. Concentrations of glucose and acute-phase reactants had returned to those before treatment at the follow-up visit.\nCONCLUSION/INTERPRETATION: In Type II diabetic patients serum amyloid A and complement protein C3 are raised. Troglitazone exerts a selective reversible action on some acute-phase proteins and C3 but not on others in conjunction with the improvement in glucose metabolism.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s001250051315", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "name": "Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes", 
    "pagination": "1433-1438", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f9f0f2cb7b6a989cfa9ab14d45844c5bf34b794f7989a8270b1f02d06d12cdf4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "10651262"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s001250051315"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052471842"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s001250051315", 
      "https://app.dimensions.ai/details/publication/pub.1052471842"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113650_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs001250051315"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s001250051315'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s001250051315'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s001250051315'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s001250051315'


 

This table displays all metadata directly associated to this object as RDF triples.

314 TRIPLES      21 PREDICATES      77 URIs      44 LITERALS      32 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s001250051315 schema:about N02a3710b31ac418eb7568d5c878fe619
2 N3c43ec97de74440d84bc97453df894e9
3 N45dde3a4bc5542438e922507b977ba91
4 N4bdfed813a0445edb8120b9b8483d6ec
5 N6933b3797ee945c1b5b20a0463fd7faa
6 N6f5b76e9b1e04a40aa781c1de540f4e0
7 N71e68d14a88f494a9521b40afc589af6
8 N77689c687a524f948d02d29e5357d0ec
9 N868b088d05ea444da16b5def52c5d01a
10 N8a68484b3c48437cb7b936247a1b2c00
11 N97d26a22f0c042069fd0be332a60e883
12 N9a0fc310c5f64399a5b953c00b2e5fe3
13 Na02c39146dc34183a4ebb298e1caff72
14 Na09c42204e9d4213a621972c96edd04e
15 Na0dbcc42672a4a27bbf009775b76a26e
16 Nabd14ff4b84648f9b64d8ac5a9155d7d
17 Nada12e123427478e80be23f44d56208d
18 Nb3fc66c628d64764993b3d7594905934
19 Nc97af861233240519684dfdd60badff2
20 Ne3b5ab64966441099967a93206806b76
21 Nf2b703d88b714284bba1f5822d4a0f2e
22 Nf98dde787443470685ab715606a8a294
23 Nfeb2bced6b24400ebdad670f3aa46c5b
24 anzsrc-for:11
25 anzsrc-for:1103
26 schema:author Ned84c712f46449cdac47ec0cd1848e04
27 schema:citation sg:pub.10.1007/s001250050822
28 sg:pub.10.1007/s001250050901
29 sg:pub.10.1038/34178
30 sg:pub.10.1038/34184
31 https://doi.org/10.1016/0026-0495(89)90038-3
32 https://doi.org/10.1016/0092-8674(95)90193-0
33 https://doi.org/10.1016/0092-8674(95)90194-9
34 https://doi.org/10.1016/0167-5699(94)90138-4
35 https://doi.org/10.1016/s0092-8674(00)81359-8
36 https://doi.org/10.1016/s0092-8674(00)81567-6
37 https://doi.org/10.1021/bi00198a014
38 https://doi.org/10.1021/jm950395a
39 https://doi.org/10.1042/cs0680233
40 https://doi.org/10.1046/j.1365-2249.1997.3921287.x
41 https://doi.org/10.1046/j.1365-3083.1997.d01-147.x
42 https://doi.org/10.1055/s-0029-1210817
43 https://doi.org/10.1056/nejm199408183310709
44 https://doi.org/10.1056/nejm199411033311803
45 https://doi.org/10.1056/nejm199705223362103
46 https://doi.org/10.1074/jbc.270.22.12953
47 https://doi.org/10.1111/j.1749-6632.1982.tb22139.x
48 https://doi.org/10.1159/000186276
49 https://doi.org/10.2337/diab.44.4.471
50 https://doi.org/10.2337/diab.46.3.451
51 https://doi.org/10.2337/diacare.15.2.193
52 schema:datePublished 1999-12
53 schema:datePublishedReg 1999-12-01
54 schema:description AIMS/HYPOTHESIS: Inflammation could play a part in insulin resistance. Thiazolidinediones, new antidiabetic drugs, possess anti-inflammatory effects in vitro. We investigated if acute-phase serum proteins are increased in patients with Type II (non-insulin-dependent) diabetes mellitus who had been treated with insulin and whether troglitazone has anti-inflammatory effects in vivo. METHODS: A total of 27 patients (age 63.0+/-1.7 years, HbA1c 8.8+/-0.3%, BMI 32.7+/-0.8 kg/m2, duration 15.2+/-1.4 years, insulin dose 73.3+/-7.0 U/day) participated in the study. The patients received daily either 400 mg troglitazone or placebo for 16 weeks. Blood samples were taken at baseline, at the end of therapy and after a follow-up time of 23+/-4 days. RESULTS: The concentrations of serum amyloid A (6.2+/-1.1 mg/l) and C-reactive protein (6.1+/-1.1 mg/l) were increased (p < 0.001) and complement protein C3 (1.69+/-0.05 g/l) was also above the reference range for healthy subjects. Placebo treatment had no effect on glucose or inflammation, whereas troglitazone reduced fasting glucose (from 10.4+/-0.6 mmol/l to 8.1+/-0.5 mmol/l, p < 0.01), HbA1c (from 8.7+/-0.3% to 7.5+/-0.3%, p < 0.01), insulin requirements (from 75+/-10 U/day to 63+/-10 U/day, p < 0.05), serum amyloid A (from 6.3+/-1.5 mg/l to 4.0+/-1.3 mg/l, p = 0.001), alpha-1-acid glycoprotein (from 906+/-51 mg/l to 729+/-52 mg/l, p = 0.001) and C3 (from 1.72+/-0.07 g/l to 1.66+/-0.06 g/l, p < 0.05) but not alpha-1-antitrypsin, ceruloplasmin, C-reactive protein or haptoglobin significantly. Concentrations of glucose and acute-phase reactants had returned to those before treatment at the follow-up visit. CONCLUSION/INTERPRETATION: In Type II diabetic patients serum amyloid A and complement protein C3 are raised. Troglitazone exerts a selective reversible action on some acute-phase proteins and C3 but not on others in conjunction with the improvement in glucose metabolism.
55 schema:genre research_article
56 schema:inLanguage en
57 schema:isAccessibleForFree true
58 schema:isPartOf N2c2df832fc6e4abb86c12a4a7f75e242
59 Nb7d5543e99294c0abd9568996af0fc69
60 sg:journal.1001482
61 schema:name Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes
62 schema:pagination 1433-1438
63 schema:productId N972c225d51b347b7ae1f7be39f606f1b
64 Na489c6f605f54a24b376d1d7f0dc50b1
65 Nd04d741ff3e944b5b8b6c28f4c943d44
66 Nd63970bc96ba4cf48290f6e899132439
67 Nfe97b192f6084af6835c3916c3389187
68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052471842
69 https://doi.org/10.1007/s001250051315
70 schema:sdDatePublished 2019-04-11T10:31
71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
72 schema:sdPublisher N6c7803fccb41466f8767272bb21cad0d
73 schema:url https://link.springer.com/10.1007%2Fs001250051315
74 sgo:license sg:explorer/license/
75 sgo:sdDataset articles
76 rdf:type schema:ScholarlyArticle
77 N02a3710b31ac418eb7568d5c878fe619 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Diabetes Mellitus, Type 2
79 rdf:type schema:DefinedTerm
80 N06d1db58348644b6b209cb29eaa27d58 rdf:first sg:person.01076177743.72
81 rdf:rest Ne081dc4323d84ac69a1e9defa692650c
82 N136e9ba7bae247db8471f218c6229431 rdf:first Nd7f462eb51644275b153872cec4537ec
83 rdf:rest Nedecae384cdd410ebac988136d1b3d1a
84 N2c2df832fc6e4abb86c12a4a7f75e242 schema:issueNumber 12
85 rdf:type schema:PublicationIssue
86 N3b357982341240d68379145a8ea39f0a rdf:first sg:person.01102740042.78
87 rdf:rest N136e9ba7bae247db8471f218c6229431
88 N3c43ec97de74440d84bc97453df894e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Lipids
90 rdf:type schema:DefinedTerm
91 N45dde3a4bc5542438e922507b977ba91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Thiazolidinediones
93 rdf:type schema:DefinedTerm
94 N4bdfed813a0445edb8120b9b8483d6ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Blood Glucose
96 rdf:type schema:DefinedTerm
97 N5e7d09daeecc4ad4b0b4b701dfb885a3 rdf:first Nc5c41982d744402c8b0ba9211b7af640
98 rdf:rest Nb1958af6b5fe413ea73901d0e4a3a9de
99 N6933b3797ee945c1b5b20a0463fd7faa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Complement C3
101 rdf:type schema:DefinedTerm
102 N6c7803fccb41466f8767272bb21cad0d schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 N6f5b76e9b1e04a40aa781c1de540f4e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Female
106 rdf:type schema:DefinedTerm
107 N71e68d14a88f494a9521b40afc589af6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Acute-Phase Proteins
109 rdf:type schema:DefinedTerm
110 N77689c687a524f948d02d29e5357d0ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Hypoglycemic Agents
112 rdf:type schema:DefinedTerm
113 N7886a7e1746d4aaf9c9700595671e0e3 rdf:first sg:person.0606507046.23
114 rdf:rest rdf:nil
115 N79707be7a8d7498b982a46cf339aba3a rdf:first sg:person.01063043575.68
116 rdf:rest N7886a7e1746d4aaf9c9700595671e0e3
117 N868b088d05ea444da16b5def52c5d01a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Placebos
119 rdf:type schema:DefinedTerm
120 N8a68484b3c48437cb7b936247a1b2c00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Aged
122 rdf:type schema:DefinedTerm
123 N972c225d51b347b7ae1f7be39f606f1b schema:name doi
124 schema:value 10.1007/s001250051315
125 rdf:type schema:PropertyValue
126 N97d26a22f0c042069fd0be332a60e883 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Double-Blind Method
128 rdf:type schema:DefinedTerm
129 N9a0fc310c5f64399a5b953c00b2e5fe3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Glycated Hemoglobin A
131 rdf:type schema:DefinedTerm
132 Na02c39146dc34183a4ebb298e1caff72 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Troglitazone
134 rdf:type schema:DefinedTerm
135 Na09c42204e9d4213a621972c96edd04e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Chromans
137 rdf:type schema:DefinedTerm
138 Na0dbcc42672a4a27bbf009775b76a26e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Body Mass Index
140 rdf:type schema:DefinedTerm
141 Na489c6f605f54a24b376d1d7f0dc50b1 schema:name dimensions_id
142 schema:value pub.1052471842
143 rdf:type schema:PropertyValue
144 Nabd14ff4b84648f9b64d8ac5a9155d7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Orosomucoid
146 rdf:type schema:DefinedTerm
147 Nada12e123427478e80be23f44d56208d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name C-Reactive Protein
149 rdf:type schema:DefinedTerm
150 Nb1958af6b5fe413ea73901d0e4a3a9de rdf:first sg:person.0715423117.02
151 rdf:rest N79707be7a8d7498b982a46cf339aba3a
152 Nb3fc66c628d64764993b3d7594905934 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Serum Amyloid A Protein
154 rdf:type schema:DefinedTerm
155 Nb7d5543e99294c0abd9568996af0fc69 schema:volumeNumber 42
156 rdf:type schema:PublicationVolume
157 Nc5c41982d744402c8b0ba9211b7af640 schema:affiliation https://www.grid.ac/institutes/grid.417201.1
158 schema:familyName Bergkulla
159 schema:givenName S.
160 rdf:type schema:Person
161 Nc97af861233240519684dfdd60badff2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Humans
163 rdf:type schema:DefinedTerm
164 Nd04d741ff3e944b5b8b6c28f4c943d44 schema:name nlm_unique_id
165 schema:value 0006777
166 rdf:type schema:PropertyValue
167 Nd63970bc96ba4cf48290f6e899132439 schema:name readcube_id
168 schema:value f9f0f2cb7b6a989cfa9ab14d45844c5bf34b794f7989a8270b1f02d06d12cdf4
169 rdf:type schema:PropertyValue
170 Nd7f462eb51644275b153872cec4537ec schema:affiliation https://www.grid.ac/institutes/grid.15485.3d
171 schema:familyName Koistinen
172 schema:givenName H. A.
173 rdf:type schema:Person
174 Ne081dc4323d84ac69a1e9defa692650c rdf:first sg:person.01071674535.03
175 rdf:rest N5e7d09daeecc4ad4b0b4b701dfb885a3
176 Ne3b5ab64966441099967a93206806b76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Male
178 rdf:type schema:DefinedTerm
179 Ned84c712f46449cdac47ec0cd1848e04 rdf:first sg:person.0744473260.52
180 rdf:rest N3b357982341240d68379145a8ea39f0a
181 Nedecae384cdd410ebac988136d1b3d1a rdf:first sg:person.016547631637.99
182 rdf:rest N06d1db58348644b6b209cb29eaa27d58
183 Nf2b703d88b714284bba1f5822d4a0f2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Insulin
185 rdf:type schema:DefinedTerm
186 Nf98dde787443470685ab715606a8a294 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Thiazoles
188 rdf:type schema:DefinedTerm
189 Nfe97b192f6084af6835c3916c3389187 schema:name pubmed_id
190 schema:value 10651262
191 rdf:type schema:PropertyValue
192 Nfeb2bced6b24400ebdad670f3aa46c5b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Middle Aged
194 rdf:type schema:DefinedTerm
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
199 schema:name Clinical Sciences
200 rdf:type schema:DefinedTerm
201 sg:journal.1001482 schema:issn 0012-186X
202 1432-0428
203 schema:name Diabetologia
204 rdf:type schema:Periodical
205 sg:person.01063043575.68 schema:affiliation https://www.grid.ac/institutes/grid.460356.2
206 schema:familyName Saltevo
207 schema:givenName J.
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063043575.68
209 rdf:type schema:Person
210 sg:person.01071674535.03 schema:affiliation https://www.grid.ac/institutes/grid.417201.1
211 schema:familyName Nissén
212 schema:givenName M.
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071674535.03
214 rdf:type schema:Person
215 sg:person.01076177743.72 schema:affiliation https://www.grid.ac/institutes/grid.410552.7
216 schema:familyName Rönnemaa
217 schema:givenName T.
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076177743.72
219 rdf:type schema:Person
220 sg:person.01102740042.78 schema:affiliation https://www.grid.ac/institutes/grid.15485.3d
221 schema:familyName Teppo
222 schema:givenName A. -M.
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102740042.78
224 rdf:type schema:Person
225 sg:person.016547631637.99 schema:affiliation https://www.grid.ac/institutes/grid.410552.7
226 schema:familyName Viikari
227 schema:givenName J.
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016547631637.99
229 rdf:type schema:Person
230 sg:person.0606507046.23 schema:affiliation https://www.grid.ac/institutes/grid.15485.3d
231 schema:familyName Koivisto
232 schema:givenName V. A.
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0606507046.23
234 rdf:type schema:Person
235 sg:person.0715423117.02 schema:affiliation https://www.grid.ac/institutes/grid.412326.0
236 schema:familyName Salmela
237 schema:givenName P.
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715423117.02
239 rdf:type schema:Person
240 sg:person.0744473260.52 schema:affiliation https://www.grid.ac/institutes/grid.15485.3d
241 schema:familyName Ebeling
242 schema:givenName P.
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744473260.52
244 rdf:type schema:Person
245 sg:pub.10.1007/s001250050822 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046557332
246 https://doi.org/10.1007/s001250050822
247 rdf:type schema:CreativeWork
248 sg:pub.10.1007/s001250050901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037565164
249 https://doi.org/10.1007/s001250050901
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/34178 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037539688
252 https://doi.org/10.1038/34178
253 rdf:type schema:CreativeWork
254 sg:pub.10.1038/34184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017942021
255 https://doi.org/10.1038/34184
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1016/0026-0495(89)90038-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026152682
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1016/0092-8674(95)90193-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035230198
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1016/0092-8674(95)90194-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002104062
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1016/0167-5699(94)90138-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028438524
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1016/s0092-8674(00)81359-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001926405
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/s0092-8674(00)81567-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040162482
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1021/bi00198a014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055164844
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1021/jm950395a schema:sameAs https://app.dimensions.ai/details/publication/pub.1055957129
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1042/cs0680233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1056722386
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1046/j.1365-2249.1997.3921287.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1007691635
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1046/j.1365-3083.1997.d01-147.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046834839
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1055/s-0029-1210817 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057183318
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1056/nejm199408183310709 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000631503
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1056/nejm199411033311803 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031657081
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1056/nejm199705223362103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048761446
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1074/jbc.270.22.12953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015129002
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1111/j.1749-6632.1982.tb22139.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006279574
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1159/000186276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053678512
292 rdf:type schema:CreativeWork
293 https://doi.org/10.2337/diab.44.4.471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070737544
294 rdf:type schema:CreativeWork
295 https://doi.org/10.2337/diab.46.3.451 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070738139
296 rdf:type schema:CreativeWork
297 https://doi.org/10.2337/diacare.15.2.193 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070745623
298 rdf:type schema:CreativeWork
299 https://www.grid.ac/institutes/grid.15485.3d schema:alternateName Helsinki University Central Hospital
300 schema:name Division of Internal Medicine and Geriatrics, Department of Medicine, Helsinki University Central Hospital, Finland, FI
301 Division of Nephrology, Department of Medicine, Helsinki University Central Hospital, Finland, FI
302 rdf:type schema:Organization
303 https://www.grid.ac/institutes/grid.410552.7 schema:alternateName Turku University Hospital
304 schema:name Department of Medicine, Turku University Central Hospital, Finland, FI
305 rdf:type schema:Organization
306 https://www.grid.ac/institutes/grid.412326.0 schema:alternateName Oulu University Hospital
307 schema:name Department of Medicine, Oulu University Hospital, Finland, FI
308 rdf:type schema:Organization
309 https://www.grid.ac/institutes/grid.417201.1 schema:alternateName Vaasa Central Hospital
310 schema:name Department of Medicine, Vaasa Central Hospital, Finland, FI
311 rdf:type schema:Organization
312 https://www.grid.ac/institutes/grid.460356.2 schema:alternateName Central Finland Health Care District
313 schema:name Department of Medicine, Jyväskylä Central Hospital, Finland, FI
314 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...